KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Johnson & Johnson (JNJ) Share-based Compensation (2016 - 2025)

Johnson & Johnson's Share-based Compensation history spans 17 years, with the latest figure at $309.0 million for Q4 2025.

  • For Q4 2025, Share-based Compensation rose 29.83% year-over-year to $309.0 million; the TTM value through Dec 2025 reached $1.4 billion, up 15.14%, while the annual FY2025 figure was $1.4 billion, 15.14% up from the prior year.
  • Share-based Compensation for Q4 2025 was $309.0 million at Johnson & Johnson, down from $347.0 million in the prior quarter.
  • Across five years, Share-based Compensation topped out at $410.0 million in Q2 2025 and bottomed at $160.0 million in Q1 2021.
  • The 5-year median for Share-based Compensation is $299.0 million (2023), against an average of $292.7 million.
  • The largest annual shift saw Share-based Compensation dropped 18.35% in 2023 before it soared 33.71% in 2024.
  • A 5-year view of Share-based Compensation shows it stood at $259.0 million in 2021, then rose by 7.34% to $278.0 million in 2022, then crashed by 35.97% to $178.0 million in 2023, then surged by 33.71% to $238.0 million in 2024, then rose by 29.83% to $309.0 million in 2025.
  • Per Business Quant, the three most recent readings for JNJ's Share-based Compensation are $309.0 million (Q4 2025), $347.0 million (Q3 2025), and $410.0 million (Q2 2025).